ClinicalTrials数据库提供临床试验Tris-CAR-T Cell Therapy for Recurrent Glioblastoma的登记号NCT05577091,试验分期Phase 1以及申办者Beijing Tiantan Hospital的信息,更过关于临床试验的其他信息查询就在戊戌数据美国临床试验数据库.
通过这些技术,研究人员成功开发出了一种名为Tris-CAR-T的新疗法,这是我国首个自主研发的神经肿瘤双靶CAR-T细胞疗法。 Tris-CAR-T疗法的独特之处在于它将肿瘤干细胞作为治疗靶点,具有优越的肿瘤特异性和普适性。此外,相关增强序列的引入显著加强了CAR-T细胞的增殖与杀伤活性。目前,该疗法已在临床试验中显示出较好...
Human Exposure Assessment of Tris (1-chloro-2-propyl) phosphate (TCIPP) via Dermal Contact with Car Dustdoi:10.56714/bjrs.49.1.10IRAQTODDLERSDUSTSKIN absorptionFIREPROOFING agentsAGE groupsINVESTIGATION reportsTris (1-chloro-2-propyl) phosphate (TCIPP) synthesis halogenated organophosphate ...
待分类 > 待分类 > Samarium(III) compounds supported by the hydrotris(3,5-dimethyl-pyrazolyl)borate ligand synthetic utility of the putative, reduction prone Sm(III)-hydrocarbyls, ‘(T..下载文档 收藏 打印 转格式 Samarium(III) compounds supported by the hydrotris(3,5-dimethyl-pyrazolyl)borate...
Fluoride-hexafluorosilicate-tris[bis-(dimethyl-glyoxi-ma-to)di(thio-car-ba-mi-de)cobalt (III)] sesquishydrate manifesting biosti-mulating propertiesThe invention relates to a new coordinative compound class on the cobalt and dimet-hylglyoxime base that can be applied as catalysts and bio...
Tris-CAR-T疗法的独特之处在于它将肿瘤干细胞作为治疗靶点,具有优越的肿瘤特异性和普适性。此外,相关增强序列的引入显著加强了CAR-T细胞的增殖与杀伤活性。目前,该疗法已在临床试验中显示出较好的疗效和安全性。这一成果不仅标志着我国在神经肿瘤CAR-T产品研发方面取得了重要进展,也为其他实体肿瘤的治疗提供了新的思...